Multi‐pathway‐driven hepatic protection: Semaglutide combined with HIIT counteracts diabetic liver injury in db/db mice
Semaglutide combined with HIIT synergistically improves hepatic glucose and lipid metabolism in diabetic mice, providing a new treatment strategy for liver lipid disorders.
Authors
- Shenglong Le (ORCID: https://orcid.org/0000-0003-0925-9660)
- Yuxin Xiao
- Xiaoyan Chen (ORCID: https://orcid.org/0000-0002-4456-660X)
- Junhua Wang (ORCID: https://orcid.org/0000-0002-6110-3711)
- Feng Gao (ORCID: https://orcid.org/0009-0004-1635-4775)
- Wenjun Yu
- Yongfu Liu
Institutions
- Hubei University of Medicine (CN)
- Shanghai Jiao Tong University (CN)
- Taihe Hospital (CN)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1111/jdi.70174
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hubei University of Medicine
- Hubei University